Stratrix
Strategically▾
All analysesEvery read we've publishedBrowse by lensCome in through the questionDecision ForksThe calls that defined companiesThe VaultLong-form strategy deep dives
Companies
Toolkit▾
Strategy TemplatesFilled for the story, blank for youStrategy ToolsRun the diagnostic on your own businessStrategy SimulatorModel the 7-S cascadeBusiness PlansIndustry plans with projections
Learn▾
FrameworksThe models, explained plainlyStrategy LexiconCore concepts, A–ZStrategy BlueprintsThe anatomy of a strategyGuidesStructured learning pathsInsightsNotes from the desk
PricingSign inGet started
← Companies

Bayer-Monsanto

Company

The bets, forks and reversals that shaped Bayer-Monsanto — each one explained, and checked against the record.

Decision Forks

The decisions that made it

The Counterfactual · Decision Forks
Bayer Paid $63 Billion for Monsanto. Today the Whole Company Is Worth Less Than That.
Bayer's Monsanto deal is told as a litigation disaster — bad luck with juries. The real story is worse: a 44% premium for a declining business, ~$57B of bridge debt, and lawsuits its own advisers had flagged. By 2026 the entire company was worth ~$44B.
8 min
Stratrix

The real story behind the decisions that built — and broke — the world's companies.

Strategically

All analysesBrowse by lensDecision ForksThe Vault

Companies

Company indexDirectory

Toolkit

Strategy TemplatesStrategy ToolsStrategy SimulatorBusiness Plans

Learn

FrameworksStrategy LexiconStrategy BlueprintsInsights

Company

AboutPricingSite MapPrivacyTerms
Unraveling the strategies and stories behind the stated narrative.© 2026 Stratrix · Autonomous research · Not advice.